Purple pitcher plant
- Generic Name
- Purple pitcher plant
- Drug Type
- Biotech
- Unique Ingredient Identifier
- FOP08H143P
Overview
Sarracenia purpurea, commonly known as the purple pitcher plant, northern pitcher plant, turtle socks, or side-saddle flower, is a perennial carnivorous plant in the family Sarraceniaceae. Sarracenia purpurea attract and trap insects within their pitchers, or fused leaves, to consume nitrogen during the digestion process . It is widely distributed across North America and has been used as a traditional medicinal herb in many aboriginal communities . It was used as an injectable pain reliever and during the 19th century, Sarracenia purpurea was used as a treatment of smallpox . Compounds extracted from Sarracenia purpurea include phenolic glycosides, flavonoid glycosides, and iridoids. In vitro, there is evidence of glycosides potentiating glucose uptake with potential antidiabetic properties . Cytoprotection in an in vitro model of diabetic neuropathy has also been studied. However, the use of Sarracenia Purpurea extracts in the clinical setting are limited.
Background
Sarracenia purpurea, commonly known as the purple pitcher plant, northern pitcher plant, turtle socks, or side-saddle flower, is a perennial carnivorous plant in the family Sarraceniaceae. Sarracenia purpurea attract and trap insects within their pitchers, or fused leaves, to consume nitrogen during the digestion process . It is widely distributed across North America and has been used as a traditional medicinal herb in many aboriginal communities . It was used as an injectable pain reliever and during the 19th century, Sarracenia purpurea was used as a treatment of smallpox . Compounds extracted from Sarracenia purpurea include phenolic glycosides, flavonoid glycosides, and iridoids. In vitro, there is evidence of glycosides potentiating glucose uptake with potential antidiabetic properties . Cytoprotection in an in vitro model of diabetic neuropathy has also been studied. However, the use of Sarracenia Purpurea extracts in the clinical setting are limited.
Indication
No approved therapeutic indications.
Associated Conditions
- Pain
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|---|---|---|---|---|
ORAL | 12 [hp_X] in 1 mL | 2025/05/27 | 43742-2108 | ||
ORAL | 12 [hp_X] in 1 mL | 2025/05/07 | 43742-2263 |
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|
No NMPA products found
No NMPA products found for this drug
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug